Post-traumatic Stress Disorder (PTSD) Clinical Trial
Official title:
MemoTV: Epigenetic, Neural and Cognitive Memories of Traumatic Stress and Violence in Former Offenders of the Townships of South Africa
Escalating violence is omnipresent in South African townships and can be traced back to two core mechanisms: a trauma-related hyper-arousal and a positive rewarding perception of violence. In the past, there was no therapeutic intervention available addressing both, trauma and the so-called appetitive aggression. The University of Konstanz has developed a culturally sensitive and scientifically based short-term intervention for the treatment of traumatized patients, the Narrative Exposure Therapy (NET), that has proven its effectiveness in various randomized clinical studies in different war-affected populations. Recently, the NET has been adapted for the forensic offender rehabilitation (FORNET) by also addressing the perpetration of violence related to a self-rewarding perception of the exposure with violence. It has shown to be effective in reducing the number of committed offenses in a perpetrator sample in Burundi and to reduce PTSD symptoms in a perpetrator sample in the Democratic Republic of the Congo. In this study, we investigated the therapeutic efficiency of FORNET in a randomized clinical control trial with a sample of former offenders of the townships of Cape Town. In addition to the previous studies, we specifically addressed the context of ongoing stress and linked our findings to epigenetic markers of stress and violence. Participants were followed over a period of up to 25-months post-treatment. The FORNET was also disseminated to local staff of our collaboration partners from the South African Universities and an organization working in the townships to warrant sustainability of the therapeutic intervention.
Status | Completed |
Enrollment | 45 |
Est. completion date | March 2016 |
Est. primary completion date | March 2016 |
Accepts healthy volunteers | No |
Gender | Male |
Age group | 10 Years to 40 Years |
Eligibility |
Inclusion Criteria: - High levels of PTSD symptoms (i.e. Scores on the PSS-I > 7 points) - High levels of appetitive aggression (i.e. Scores on the Appetitive Aggression Scale (AAS) > 8 points) - participants are recruited through the community based re-integration program Exclusion Criteria: - acute psychotic episode |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
University of Konstanz | University of Cape Town, University of Stellenbosch |
South Africa,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in PTSD symptom severity with the PSS-I the Post-traumatic Stress Disorder Scale- Interview (PSS-I) post-treatment at 6- and 12-month follow-up | 8, 18 and 25- month follow-up | No | |
Primary | Change in Attraction to violence with the Appetitive Aggression Scale (AAS) post-treatment at 6- and 12-month follow-up | 8, 18 and 25- month follow-up | No | |
Primary | Change in Methylation Pattern of the Glucocorticoid Receptor promoter region via saliva samples | 8, 18 and 25- month follow-up | No | |
Primary | Change in Self-committed violence with the AAS offense list | 8, 18 and 25- month follow-up | No | |
Primary | Influence of Social Acknowledgement with Social Acknowledgement Questionnaire (SAQ) | 8, 18 and 25- month follow-up | No | |
Primary | Influence of drug abuse related to violence on number of offenses with the offense checklist (from the AAS) | 8, 18 and 25- month follow-up | No | |
Primary | Change in Epigenetic Markers (methylation patterns) of violence in the androgen receptor promoter region via saliva samples | 8, 18 and 25- month follow-up | No | |
Secondary | Change in Strength of suicidal ideation measured with the MINI 6.0.0. | 8, 18 and 25- month follow-up | No | |
Secondary | Change in Psychosocial Functioning measured with the WSAS (Work and Social Adjustment Scale) | 8, 18 and 25- month follow-up | No | |
Secondary | Change in Depression severity with the PHQ-9 | 8, 18 and 25- month follow-up | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT05189977 -
A Trial to Assess the Effects of Prazosin or Propranolol on Blood Pressure in the Presence of Brexpiprazole/Sertraline
|
Phase 1 | |
Completed |
NCT01806168 -
rTMS in the Treatment of PTSD
|
N/A | |
Not yet recruiting |
NCT06194851 -
Examining Intranasal Oxytocin Augmentation of Brief Couples Therapy for Veterans With PTSD
|
Phase 2 | |
Completed |
NCT02187224 -
Progesterone Effect on Individuals Diagnoses With AD and PTSD.
|
Phase 2/Phase 3 | |
Completed |
NCT02549508 -
Comparison Study Using APAP With and Without SensAwake in Patients With OSA and PTSD
|
N/A | |
Not yet recruiting |
NCT01940549 -
Transcranial Direct Current Stimulation (tDCS) Enhancement of Trauma-focused Therapy for Posttraumatic Stress Disorder
|
N/A | |
Not yet recruiting |
NCT06419959 -
NightWare and Cardiovascular Health in Veterans With PTSD
|
N/A | |
Terminated |
NCT03209882 -
Transcranial Infrared Laser Stimulation (TILS) of Prefrontal Cognition in Post-traumatic Stress Disorder (PTSD)
|
N/A | |
Completed |
NCT04891614 -
The PRISM Pilot Trial for Post-Traumatic Stress Disorder
|
N/A | |
Recruiting |
NCT05407337 -
The Effect of Narrative Exposure Therapy Intervention on Post-traumatic Stress Dissorder and Personal Recovery in Refugees and Asylum Seekers of Sindiane Programme
|
N/A | |
Completed |
NCT02030522 -
Prospective Cohort Study of Accelerated Resolution Therapy (ART) for Treatment of Military Psychological Trauma
|
N/A | |
Completed |
NCT01729325 -
Prevention of Post-Traumatic Stress Disorder in Soldiers
|
Phase 2 | |
Completed |
NCT02053532 -
Functional Brain Imaging in PTSD
|
N/A | |
Not yet recruiting |
NCT02598024 -
Treating Earthquake in Nepal Trauma (TENT) Trial 2016
|
N/A | |
Terminated |
NCT02237703 -
Kappa Opioid Receptor Imaging in Post-traumatic Stress Disorder (PTSD)
|
N/A | |
Withdrawn |
NCT02356861 -
LED Light Therapy to Improve Cognitive & Psychosocial Function in TBI-PTSD Veterans
|
N/A | |
Not yet recruiting |
NCT05974631 -
Evaluating Treatments for Suicidal Veterans With PTSD
|
N/A | |
Not yet recruiting |
NCT06288594 -
TraumaRelief App: A Pilot RCT Assessing Feasibility and Acceptability
|
N/A | |
Completed |
NCT01847469 -
Zonisamide in Addition to E-CPT-C for Veterans With PTSD and Comorbid Alcohol Dependence
|
Phase 2 | |
Terminated |
NCT02237677 -
CB1 Receptor PET Imaging Reveals Gender Differences in PTSD
|
N/A |